These patent working papers identify the most relevant patents for each medicine. The patents are categorized in primary and secondary patents. The patent publication covering the base compound is considered the “primary patent” and patents on specific pharmaceutical formulations, method of use, product derivatives, and processes are considered “secondary patents”. Secondary patents are generally easier to circumvent (“to invent around”), meaning to make the medicine without infringing the secondary patents.